Home > National Drug Code (NDC) > Spironolactone and Hydrochlorothiazide

Spironolactone and Hydrochlorothiazide - 51079-104-20 - (spironolactone and hydrochlorothiazide)

Alphabetical Index


Drug Information of Spironolactone and Hydrochlorothiazide

Product NDC: 51079-104
Proprietary Name: Spironolactone and Hydrochlorothiazide
Non Proprietary Name: spironolactone and hydrochlorothiazide
Active Ingredient(s): 25; 25    mg/1; mg/1 & nbsp;   spironolactone and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Spironolactone and Hydrochlorothiazide

Product NDC: 51079-104
Labeler Name: UDL Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA086513
Marketing Category: ANDA
Start Marketing Date: 20110823

Package Information of Spironolactone and Hydrochlorothiazide

Package NDC: 51079-104-20
Package Description: 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-104-20) > 1 TABLET in 1 BLISTER PACK (51079-104-01)

NDC Information of Spironolactone and Hydrochlorothiazide

NDC Code 51079-104-20
Proprietary Name Spironolactone and Hydrochlorothiazide
Package Description 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-104-20) > 1 TABLET in 1 BLISTER PACK (51079-104-01)
Product NDC 51079-104
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name spironolactone and hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20110823
Marketing Category Name ANDA
Labeler Name UDL Laboratories, Inc.
Substance Name HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
Strength Number 25; 25
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Spironolactone and Hydrochlorothiazide


General Information